Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10092181
Abstract: Severe asthma is characterized by different endotypes driven by complex pathologic mechanisms. In most patients with both allergic and non-allergic asthma, predominant eosinophilic airway inflammation is present. Given the central role of eosinophilic inflammation in… read more here.
Keywords: inflammation; inflammation appealing; target pharmacologic; eosinophilic inflammation ... See more keywords